These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 1346577)
1. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA). Estey EH; Kurzrock R; Kantarjian HM; O'Brien SM; McCredie KB; Beran M; Koller C; Keating MJ; Hirsch-Ginsberg C; Huh YO Blood; 1992 Feb; 79(4):882-7. PubMed ID: 1346577 [TBL] [Abstract][Full Text] [Related]
2. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. Piro LD; Carrera CJ; Carson DA; Beutler E N Engl J Med; 1990 Apr; 322(16):1117-21. PubMed ID: 1969613 [TBL] [Abstract][Full Text] [Related]
3. Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2'-deoxyadenosine (CdA): relation to opportunistic infections. Juliusson G; Liliemark J Blood; 1992 Feb; 79(4):888-94. PubMed ID: 1346578 [TBL] [Abstract][Full Text] [Related]
4. Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey. Lauria F; Rondelli D; Zinzani PL; Bocchia M; Marotta G; Salvucci M; Raspadori D; Ventura MA; Birtolo S; Forconi F; Tura S Leukemia; 1997 May; 11(5):629-32. PubMed ID: 9180283 [TBL] [Abstract][Full Text] [Related]
5. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia. Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592 [No Abstract] [Full Text] [Related]
7. 2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia. Santana VM; Mirro J; Kearns C; Schell MJ; Crom W; Blakley RL J Clin Oncol; 1992 Mar; 10(3):364-70. PubMed ID: 1346800 [TBL] [Abstract][Full Text] [Related]
8. 2-CdA in the treatment of hairy cell leukaemia. Abhyankar D; Bajpai S; Saikia T; Gopal R; Nair CN; Advani SH J Assoc Physicians India; 2001 Aug; 49():785-7. PubMed ID: 11837464 [TBL] [Abstract][Full Text] [Related]
9. 2-Chlorodeoxyadenosine treatment of low-grade lymphomas. Kay AC; Saven A; Carrera CJ; Carson DA; Thurston D; Beutler E; Piro LD J Clin Oncol; 1992 Mar; 10(3):371-7. PubMed ID: 1346801 [TBL] [Abstract][Full Text] [Related]
10. [2-CDA in treatment of hairy cell leukemia: a comparison between intravenous and subcutaneous administration. Swiss Study Group of Applied Cancer Research]. Sperb RA; von Rohr A; Ratschiller D; Bacchi M; Tichelli A; Hess U; Cerny T; Tobler A; Betticher DC Schweiz Med Wochenschr; 1998 Oct; 128(42):1593-7. PubMed ID: 9824888 [TBL] [Abstract][Full Text] [Related]
11. Hairy cell leukaemia: review of treatment. Kurzrock R; Talpaz M; Gutterman JU Br J Haematol; 1991 Oct; 79 Suppl 1():17-20. PubMed ID: 1718389 [TBL] [Abstract][Full Text] [Related]
12. The treatment of hairy cell leukemia: an update. Golomb HM; Ratain MJ; Mick R; Daly K Leukemia; 1992; 6 Suppl 2():24-7. PubMed ID: 1349662 [TBL] [Abstract][Full Text] [Related]